메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Myopathy is a rare side effect of chronic colchicine therapy, most often occurring in patients with chronic renal failure. Colchicine and 3-hydroxy-3-methy-glutaryl coenzyme A (HMG-CoA) reductase inhibitors are well known to cause myopathy. We report the case of a patient with chronic renal failure who had been taking atorvastatin and calcium channel blocker and developed acute weakness 7 days after the initiation of colchicines therapy for gouty attack. A 58-year-old woman on colchicine 0.6 mg twice a day for 7 days, developed subacute onset of painless proximal muscle weakness with elevation of creatine phosphokinase (CPK) level. Nerve conduction studies revealed a mild axonal and demyelinating neuropathy affecting the arms and legs and needle electromyography showed non-specific findings indicating myopathy. After withdrawal of colchicine, serum CPK levels returned to normal and her weakness resolved over a period. In our patient, neurological toxicity was induced and accerlated by coadministration of colchicines with atorvastatin and calcium channel blocker in the presence of impaired renal function. Colchicine is to be used with caution in patients with impaired renal function especially in those who are concomitantly administering other drugs that may further inhibit colchicine clearance.

목차

등록된 정보가 없습니다.

참고문헌 (11)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0